Gender-neutral HPV vaccination, challenging elimination of HPV and HPV-associated cancers
Monday, October 9, 2017
•
MSS 01
•
8:00 AM
>
9:30 AM
•
Gender-neutral HPV vaccination, challenging elimination of HPV and HPV-associated cancers
•
Auditorium
•
MSS 01-01
•
The theoretical basis of STI elimination
>
G.
Geoff
GARNETT
•
MSS 01-02
•
Epidemiology and burden of HPV-related diseases in males
>
A.
Anna
GIULIANO
•
MSS 01-03
•
Herd effect and overall protective effectiveness of HPV vaccination, new models
See abstract
>
I.
Iacopo
BAUSSANO
•
MSS 01-04
•
Herd effect and overall effectiveness based on randomized trials: real life evidence
>
M.
Matti
LEHTINEN
•
MSS 01-05
•
Overall effectiveness of HPV vaccination programs: An update
>
J.
Joakim
DILLNER
•
MSS 01-06
•
Gender-neutral vaccination: the role of tender pricing
See abstract
>
J.
Johannes
Berkhof
•
MSS 01-07
•
Gender-neutral vaccination program: real life example
See abstract
>
E.
Elmar
Joura
|